The Role of microRNA in Human Diseases 3.0
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 85
Special Issue Editor
2. Heidelberg Biolabs GmbH, 69120 Heidelberg, Germany
Interests: microRNA (miRNA); siRNA; cancer biology; gene regulation; molecular cloning
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is the continuation of our previous Special Issues, “The Role of microRNA in Human Diseases” and “The Role of microRNA in Human Diseases 2.0”.
MicroRNA (miRNA) is a class of small (about 22 nt long) noncoding RNAs whose main function is in the negative post-transcriptional and translational regulation of gene expression. In most cases, this regulation is mediated by the complementary binding of miRNA to the 3′ UTR of the target mRNA to promote its degradation and/or translational repression. Furthermore, multiple reports have consistently shown that aberrant miRNA expression is associated with various human diseases, including cancer and neurological and cardiovascular diseases. Finally, some host- and virus-encoded miRNAs can contribute to the process of infection by targeting certain mRNAs (both host and viral).
This Special Issue focuses on the roles of aberrant miRNA expression in different human diseases, as well as the characterization of putative miRNA targets for therapeutic intervention. In particular, studies involving advanced deep sequencing methods and novel bioinformatics algorithms for miRNA research (focus on a molecular level) are highly welcomed. The formats for submission include original research reports, reviews, and communications.
Dr. Andrey Turchinovich
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microRNA (miRNA)
- non-coding RNAs
- human diseases
- cancer
- fatty liver
- cardiovascular diseases
- neurological diseases
- viral infection
